Used as a key intermediate in the synthesis of fluorinated pharmaceutical compounds, particularly in the development of selective kinase inhibitors. Its structure supports binding to enzyme active sites with high affinity, making it valuable in oncology drug research. The acrylic acid moiety allows for conjugation or further derivatization, enabling the creation of targeted therapeutics with improved metabolic stability. Also employed in the preparation of bioactive molecules where halogen positioning enhances target specificity and potency.